Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepafenac for Post-operative Cystoid Macular Edema Prevention
NCT00494494Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jun 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nepafenac in cystoid macular edema (CME), sponsored by University of North Carolina at Chapel Hill. Started Jun 2007; status: completed.
02
Drugs
nepafenac
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT00494494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00494494.